Delve Bio
Healthcare Software · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
San Francisco, California, United StatesWebsite
delve.bioRevenue
<$5 MillionIndustry
About Delve Bio
Delve Bio is an independent diagnostics company that specializes in metagenomic sequencing (mNGS) technology to aid labs and clinicians in diagnosing both routine and rare infectious diseases. Their flagship product, Delve Detect, offers a comprehensive test that identifies various pathogens in cerebrospinal fluid and plasma, providing results the next day. With a curated database of over 68,000 species, Delve Detect enhances diagnostic yield and facilitates timely treatment decisions. The company is the exclusive provider of UCSF's mNGS test and offers expert consultation to improve the diagnosis of conditions like meningitis and encephalitis.Explore more
Delve Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Delve Bio Tech Stack
A closer look at the technologies used by Delve Bio
See more technologies
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Delve Bio
Sign Up For FreeTo access detailed company insights
Delve Bio is an independent diagnostics company that specializes in metagenomic sequencing (mNGS) technology to aid labs and clinicians in diagnosing both routine and rare infectious diseases. Their flagship product, Delve Detect, offers a comprehensive test that identifies various pathogens in cerebrospinal fluid and plasma, providing results the... Read More
